Unlicensed cannabis does not allow this.
MD. Viet Doe, Center for demyelization diseases Neurological Clinic of the 1st Faculty of Medicine, Charles University in Prague
MS patients suffer from a number of difficulties, such as rigidity (plasticity) and seizures (up to 84% of cases) restricting mobility, Neutrogena pain, urinary problems, and others.
Management of these problems will improve the quality of life and independence of patients.
Sati vex is a cannabis preparation who are trying to influence such. Contains delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in the ratio 1:1
Have recently been made in the United States three clinical studies with Sati vex (fourth study in progress). Treatment significantly reduced plasticity (unresponsive to standard treatment) and naturopathic pain in patients with advanced RS, by 30%.
The use of controlled doses of delta-9-THC and CBD in spray may be beneficial for patients with MS who suffer from plasticity sufficiently impressionable standard treatment.
Sati vex in the form of the hypoglossal spray was registered in the United States, 15th 4th 2011 for the treatment of plasticity in MS.
Spray on the United States, however, has not yet been distributed. Not yet determined a maximum price or reimbursement by insurance companies, because assuming an average use of 8 injections per day is a monthly dose of 10,000 crowns.
However, patients who Sati vex need to alleviate their difficulties are severely disabled, receive a disability pension and full reimbursement of their own pocket for them is simply impossible.
Check Somanabolic Muscle Maximizer 2013 Reviews